Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 1,655 | 4,600 | 1,072 | 623 | 1,210 |
| Cost of Goods | 109 | 18 | 118 | 170 | 467 |
| Gross Profit | 1,546 | 4,582 | 954 | 453 | 743 |
| Operating Expenses | 11,233 | 10,259 | 12,599 | 11,306 | 11,858 |
| Operating Income | -9,578 | -5,659 | -11,527 | -10,683 | -10,648 |
| Other Income | 1,454 | 946 | 638 | 699 | 724 |
| Pre-tax Income | -8,124 | -4,713 | -10,889 | -9,984 | -9,924 |
| Net Income Continuous | -8,124 | -4,713 | -10,889 | -9,984 | -9,924 |
| Net Income | $-8,124 | $-4,713 | $-10,889 | $-9,984 | $-9,924 |
| EPS Basic Total Ops | -321.90 | -209.94 | -489.85 | -447.87 | -447.87 |
| EPS Basic Continuous Ops | -326.34 | -205.13 | -491.52 | -450.73 | -448.10 |
| EPS Diluted Total Ops | -321.90 | -209.94 | -489.85 | -447.87 | -447.87 |
| EPS Diluted Continuous Ops | -326.34 | -205.13 | -491.52 | -450.73 | -448.10 |
| EBITDA(a) | $-10,765 | $-10,148 | $-11,983 | $-10,714 | $-10,680 |